Heart Valve Devices | Market Insights | Asia Pacific | 2022
The Asia Pacific heart valve device market has seen a moderately negative impact due to the global COVID-19 pandemic. However, in the long term, the market will be driven by positive results from THV device clinical trials as well as product launches, resulting in robust growth through 2030.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Asia Pacific across a 11-year period.